| 1 |
HURA
|
biotech
healthcare
|
TuHURA Biosciences, Inc.
|
6.6x
|
0.25
|
The non-linear upside is a shift from zero-revenue micro-cap biotech to a niche commercial oncology company by 2031 if IFx-2.0 reaches approval and TuHURA converts adjacent assets into partnering revenue; the main question is not whether the science could matter, but how much dilution is required to stay alive long enough to prove it.
|
| 2 |
RR
|
ai
automation
hardware
robotics
|
Richtech Robotics Inc.
|
6.0x
|
0.58
|
Richtech is a cash-rich option on physical AI adoption: if it converts early robot deployments into denser recurring service contracts, channel-led rollouts, and usable operating-data revenue before larger vendors commoditize the stack, revenue can scale non-linearly from a tiny base; if not, it stays a capital-intensive niche robot seller.
|
| 3 |
AISP
|
ai
defense
enterprise
hardware
software
|
Airship AI Holdings, Inc.
|
5.5x
|
0.60
|
Airship AI can compound far faster than its size implies if it converts federal pipeline into repeat deployments and shifts value capture from lumpy bundled projects toward sticky evidence, support, and trusted workflow software embedded in sensitive operations.
|
| 4 |
NNOX
|
ai
healthcare
medical devices
software
|
Nano-X Imaging Ltd.
|
5.4x
|
0.43
|
Nanox is a high-variance option on turning a cleared low-cost imaging device into a recurring imaging utility; if distributor volume converts into activated systems with reading, AI, and workflow attach, revenue can scale faster than the market expects even without a software-style premium.
|
| 5 |
RXRX
|
ai
automation
biotech
healthcare
software
|
Recursion Pharmaceuticals, Inc.
|
5.1x
|
0.60
|
Recursion is a proof-gated AI biotech: if REC-4881 secures a workable registration path and at least one more internal program validates platform-to-clinic repeatability, the business can shift from lumpy collaboration revenue toward a higher-quality mix of product sales, milestones, royalties, and externally financed program vehicles by 2031.
|
| 6 |
BEAM
|
biotech
healthcare
|
Beam Therapeutics Inc.
|
4.8x
|
0.44
|
Beam can rerate from a platform-discount clinical biotech into a two-franchise precision genetics company by 2031 if risto-cel reaches market and BEAM-302 converts biomarker proof into an approvable AATD product; the edge is regulated trust, delivery, and manufacturing discipline more than edit design alone.
|
| 7 |
APUS
|
ai
biotech
crypto
healthcare
|
Apimeds Pharmaceuticals US, Inc.
|
4.6x
|
0.10
|
APUS is best viewed as a distressed option on LT-100 rather than a normal operating business: if management restores filing compliance, stabilizes control, gets a fundable FDA path, and monetizes the asset through licensing or a structured partner-led launch, a shell-like valuation can rerate into a financeable pain-biotech franchise by 2031.
|
| 8 |
NTLA
|
biotech
healthcare
|
Intellia Therapeutics, Inc.
|
4.5x
|
0.38
|
If HAELO supports approval and lonvo-z launches in 2027, Intellia can move from a binary platform story to a real rare-disease franchise, with HAE funding the company, ATTR rebuilding optionality, and smarter partnering monetizing platform learning without needing full platform perfection by 2031.
|
| 9 |
MSTR
|
ai
crypto
enterprise
finance
software
|
Strategy Inc
|
4.3x
|
0.40
|
Over five years, Strategy can still create nonlinear equity upside if it keeps converting public-market demand into bitcoin faster than dilution while using its software base to evolve from seat-priced business intelligence into governed treasury, compliance, and agent-control workflows. The core upside is the financing machine plus a larger bitcoin base, not a classic software re-acceleration story.
|
| 10 |
SERV
|
ai
automation
healthcare
robotics
transportation
|
Serve Robotics Inc.
|
4.2x
|
0.64
|
Serve has a credible path to become a multi-vertical physical-AI network: if it converts today’s deployed fleet into dense, high-utilization delivery zones and turns Diligent into recurring hospital workflow revenue, the market can revalue it from a niche robot operator into a scarce real-world autonomy platform with several monetization layers.
|
| 11 |
PRME
|
ai
biotech
healthcare
|
Prime Medicine, Inc.
|
4.0x
|
0.35
|
Prime Medicine is a financing-constrained but differentiated editing platform: if PM359 secures a credible regulatory path and the 2026 liver filings translate into human validation, the stock can rerate from cash-burn optionality to a multi-asset rare-disease franchise by 2031.
|
| 12 |
DNA
|
ai
automation
biotech
healthcare
robotics
|
Ginkgo Bioworks Holdings, Inc.
|
3.9x
|
0.47
|
Post-divestiture, Ginkgo is a smaller but cleaner bet that automated lab capacity, workflow know-how, and trusted biology data can become a more repeatable R&D utility business; if utilization, contract quality, and burn improve together, the equity can still re-rate materially from a depressed base.
|
| 13 |
POET
|
ai
communications
hardware
networking
semiconductors
|
POET Technologies Inc.
|
3.6x
|
0.56
|
POET is a cash-rich, pre-scale AI optics supplier whose five-year upside depends on converting a differentiated photonics platform into repeat 800G, 1.6T and light-source shipments; if it clears manufacturing and qualification gates, it can grow from near-zero revenue into a meaningful niche supplier in AI interconnects.
|
| 14 |
SDGR
|
ai
biotech
enterprise
healthcare
software
|
Schrödinger, Inc.
|
3.6x
|
0.60
|
Schrödinger can create solid 5-year equity upside if LiveDesign becomes a deeper governed workflow layer for AI-native drug discovery, new software modules widen wallet share, and therapeutics upside is monetized mainly through partners and royalties rather than a renewed self-funded biotech burn model.
|
| 15 |
QUBT
|
ai
cybersecurity
hardware
quantum
semiconductors
|
Quantum Computing Inc.
|
3.6x
|
0.46
|
QCi is a high-optionality bet that a near-zero-revenue quantum story becomes a real photonics infrastructure supplier: if Fab 1, Luminar packaging, and NuCrypt trust products convert into repeat orders—especially in optical interconnect and secure communications—the asset base can finally earn the valuation; if not, valuation gravity wins.
|
| 16 |
MBLY
|
ai
automation
automotive
semiconductors
software
|
Mobileye Global Inc.
|
3.5x
|
0.68
|
Mobileye is a leveraged bet that AI lifts driving-feature value per vehicle faster than auto production grows; if EyeQ6-based advanced programs convert on schedule and the company monetizes validation, mapping, and in-cabin attach, the stock can rerate materially without robotaxi needing to carry the whole case.
|
| 17 |
AI
|
ai
cloud
defense
enterprise
software
|
C3.ai, Inc.
|
3.5x
|
0.40
|
C3 AI is a real but commercially damaged enterprise-AI vendor: if the restructuring improves conversion from initial deployments into scaled production contracts and shifts value capture toward trusted, regulated, outcome-linked workflows, revenue can plausibly reach a much larger base by 2031; if not, bigger platforms compress pricing and keep it subscale.
|
| 18 |
AUR
|
ai
automation
robotics
software
transportation
|
Aurora Innovation, Inc.
|
3.4x
|
0.60
|
Aurora has a credible path to turn an early U.S. driverless-trucking lead into a denser freight network with attached workflow, assurance, and financing layers, but the equity only compounds if 2026-2027 prove that observer-free launch, truck supply, and lane expansion are repeatable at industrial cadence rather than bespoke engineering wins.
|
| 19 |
CRSP
|
ai
biotech
healthcare
|
CRISPR Therapeutics AG
|
3.4x
|
0.58
|
Five-year upside comes from moving from one approved, partner-mediated therapy into a company with an established CASGEVY economics stream and one internally controlled franchise, most plausibly CTX310 or zugo-cel. The cash balance and March 2026 convert buy enough time for that second proof, but the stock still needs owned-program validation to earn a true platform rerating.
|
| 20 |
INOD
|
ai
communications
enterprise
healthcare
software
|
Innodata Inc.
|
3.4x
|
0.50
|
Innodata's five-year upside comes from converting today's frontier-AI project work into a broader trust-and-evaluation layer with lower concentration and more recurring revenue; if it succeeds, revenue can compound much faster than headcount even without a richer valuation multiple.
|
| 21 |
ACHR
|
aerospace
defense
evtol
software
transportation
|
Archer Aviation Inc.
|
3.3x
|
0.48
|
Archer is a call option on becoming one of the few certified Western eVTOL platforms, then widening from aircraft sales into recurring fleet availability, training, maintenance, regulated operating software and defense programs; if certification clears on time, value can compound non-linearly even without a mass-market air taxi network.
|
| 22 |
PDYN
|
aerospace
ai
automation
defense
software
|
Palladyne AI Corp.
|
3.3x
|
0.46
|
Palladyne can grow from a tiny base into a credible defense-autonomy supplier if 2026-2027 validations turn its software, avionics, and domestic manufacturing bundle into repeat programs; the upside is owning trusted embedded workflow positions and follow-on sustainment, not selling generic AI seats.
|
| 23 |
QBTS
|
cloud
enterprise
hardware
quantum
software
|
D-Wave Quantum Inc.
|
3.3x
|
0.50
|
D-Wave has a real shot at becoming a scaled quantum optimization infrastructure company because it already controls scarce hardware, cloud access, and commercial go-to-market, but the stock only works if 2026-2028 milestones convert early bookings and system orders into repeatable production revenue rather than staying a lumpy project business.
|
| 24 |
SMR
|
energy
hardware
nuclear
software
|
NuScale Power Corporation
|
3.2x
|
0.64
|
NuScale can still turn its approval lead into a commercial platform if it converts one U.S. flagship and one European path into bankable reference builds; that would move the story from thin engineering revenue to repeatable module, service, fuel, and trust-layer economics as AI-era power scarcity raises the value of clean firm power.
|
| 25 |
SPIR
|
aerospace
defense
software
space
|
Spire Global, Inc.
|
3.1x
|
0.60
|
Spire’s realistic five-year upside is not becoming a generic software winner; it is turning a funded orbital data asset into a more trusted defense, weather, and sovereign mission infrastructure business, with better pricing and fixed-cost absorption as the same constellation supports more high-consequence workflows.
|
| 26 |
IREN
|
ai
cloud
crypto
energy
hardware
|
IREN Limited
|
3.1x
|
0.66
|
IREN can evolve from a miner hybrid into a repeatable AI-campus developer: if it keeps converting scarce secured power into contracted AI cloud, colocation and build-to-suit revenue faster than dilution rises, revenue can scale from sub-1B today to just above 5B by 2031 and support a roughly 3x enterprise-value outcome.
|
| 27 |
OUST
|
ai
automation
hardware
robotics
software
|
Ouster, Inc.
|
3.1x
|
0.46
|
Ouster can still compound into a much larger company if the StereoLabs deal and 2026 product cycle turn it from a standalone lidar vendor into a workflow-embedded sensing stack, letting robotics, industrial, and smart-infrastructure revenue scale faster than sensor price pressure erodes value capture.
|
| 28 |
ESTC
|
ai
cloud
cybersecurity
enterprise
software
|
Elastic N.V.
|
3.0x
|
0.60
|
Elastic is a discounted AI-era context layer: if it converts embedded search, observability, and security usage into durable workflow control, regulated wins, and broader cloud commitments, revenue can more than double by 2031 and the stock can compound well above software market averages without needing a peak-SaaS multiple.
|
| 29 |
IONQ
|
cloud
defense
hardware
networking
quantum
|
IonQ, Inc.
|
3.0x
|
0.62
|
IonQ can still become a strategic quantum infrastructure winner if it converts technical leadership, trusted deployment, and broader platform scope into repeatable system sales, reserved capacity, and defense-grade workflow control before broad quantum utility becomes obvious; the upside is real, but it now depends more on execution than narrative.
|
| 30 |
RLAY
|
ai
biotech
healthcare
|
Relay Therapeutics, Inc.
|
3.0x
|
0.35
|
Relay is a clinical-proof story with bounded non-linearity: if zovegalisib wins Phase 3 and Relay builds testing, access, and evidence rails around launch, one lead asset can become a real precision-medicine franchise with vascular-anomalies upside, but the platform alone does not justify the stock.
|
| 31 |
RDVT
|
ai
enterprise
finance
software
|
Red Violet, Inc.
|
3.0x
|
0.60
|
RDVT can compound from a small base because most revenue rides verification and investigation volume, and AI should multiply those checks while the company moves from data lookup toward audit-ready KYB, fraud, and public-sector decisioning.
|
| 32 |
SMCI
|
ai
automation
cloud
enterprise
hardware
|
Super Micro Computer, Inc.
|
2.9x
|
0.45
|
Supermicro can still compound if it proves that fast AI-rack delivery, liquid-cooling integration, and one-vendor deployment are worth paying for; the stock does not need software-like economics, but it does need trust repair, cleaner cash conversion, and enough services/compliance attach to avoid being viewed as a pass-through box assembler.
|
| 33 |
NBIS
|
ai
cloud
enterprise
hardware
software
|
Nebius Group N.V.
|
2.9x
|
0.67
|
Nebius is a leveraged owner-operator of scarce AI capacity: if it converts financed power, NVIDIA supply access, and anchor contracts into live, highly utilized clusters while adding more control-plane software, revenue can scale non-linearly even as the valuation multiple compresses from today’s scarcity premium.
|
| 34 |
ZS
|
cloud
cybersecurity
enterprise
networking
software
|
Zscaler, Inc.
|
2.9x
|
0.68
|
Zscaler should outgrow mature software because its inline security position can expand from human access to workloads, data, branches, and AI-agent traffic; if it keeps shifting contracts from seats toward protected activity and turns sovereignty into regulated wins, 2031 revenue can reach 8000 and enterprise value can roughly triple without requiring a speculative multiple.
|
| 35 |
PATH
|
ai
automation
cloud
enterprise
software
|
UiPath, Inc.
|
2.8x
|
0.46
|
UiPath can roughly double revenue by 2031 if it turns its installed automation base into the governed execution layer for bots, APIs, and third-party AI agents, shifting value capture from seats toward control, trust, and workflow outcomes; from today’s compressed starting valuation, that can still support a 2-3x equity outcome.
|
| 36 |
S
|
ai
cloud
cybersecurity
enterprise
software
|
SentinelOne, Inc.
|
2.8x
|
0.60
|
SentinelOne is a control-layer bet, not a feature bet: if it keeps converting endpoint wins into sticky cloud, identity, data, and autonomous-response workflows, it can roughly triple enterprise value by 2031 without needing a category-leading valuation.
|
| 37 |
FLNC
|
automation
energy
enterprise
hardware
software
|
Fluence Energy, Inc.
|
2.8x
|
0.40
|
Fluence can roughly triple equity value by 2031 if it converts covered backlog into cleaner deliveries, uses domestic-content and utility trust to keep winning projects, and turns software, LTSA, and repower revenue into enough recurring gross profit that investors stop valuing it as only a thin-margin storage integrator.
|
| 38 |
TEM
|
ai
biotech
enterprise
healthcare
software
|
Tempus AI, Inc.
|
2.8x
|
0.70
|
Tempus can compound from a fast-growing diagnostics company into a higher-value oncology operating layer if its governed data rights and Hub/Lens workflow surfaces keep pulling more tests, evidence work, and biopharma spend into recurring contracts faster than regulation or dilution slows it.
|
| 39 |
COIN
|
crypto
enterprise
finance
software
|
Coinbase Global, Inc.
|
2.7x
|
0.60
|
Coinbase can grow from a cyclical crypto broker into a regulated execution, custody, stablecoin, and developer-rails layer; if services mix rises faster than trading fees compress, the business can compound meaningfully even without a heroic terminal multiple.
|
| 40 |
SOUN
|
ai
automation
automotive
enterprise
software
|
SoundHound AI, Inc.
|
2.7x
|
0.48
|
SoundHound can still become a meaningfully larger AI workflow company if it turns embedded voice wins and acquired assets into deeper, outcome-linked customer-service and commerce revenue; the opportunity is real, but the shareholder payoff depends on proving integration discipline and resisting application-layer pricing compression.
|
| 41 |
BFLY
|
ai
hardware
healthcare
medical devices
software
|
Butterfly Network, Inc.
|
2.7x
|
0.50
|
Butterfly has a credible path from niche handheld ultrasound vendor to regulated imaging platform: if core probe growth stays solid and newer layers like enterprise workflow, home-based care, and embedded licensing become repeatable, revenue can compound well above normal medtech without needing a pure software fantasy multiple.
|
| 42 |
AMBA
|
ai
automotive
hardware
robotics
semiconductors
|
Ambarella, Inc.
|
2.7x
|
0.60
|
Ambarella is a real edge-AI enabler: if it converts today’s design wins into sustained CV72, CV75, CV7 and N1 shipments and adds modest software, trust, and semi-custom attach, revenue can roughly triple by 2031 and enterprise value can compound at a low-20s rate without needing a speculative AI re-rating.
|
| 43 |
NOW
|
ai
automation
cloud
enterprise
software
|
ServiceNow, Inc.
|
2.6x
|
0.70
|
ServiceNow can keep compounding as AI turns enterprise workflow from a labor-saving app into the governed execution layer for agents; if it converts its installed base, CMDB, and trust posture into security, outcome pricing, and regulated automation, revenue can reach 33000 by 2031 without needing multiple expansion.
|
| 44 |
ALAB
|
ai
cloud
hardware
networking
semiconductors
|
Astera Labs, Inc.
|
2.6x
|
0.72
|
Astera can turn AI rack complexity into much higher content per deployment by expanding from retimers into switches, modules, custom fabrics and trusted lifecycle software, but the equity only compounds hard if Scorpio broadens beyond a lead customer before large buyers internalize more of the stack.
|
| 45 |
JOBY
|
aerospace
automation
defense
evtol
transportation
|
Joby Aviation, Inc.
|
2.6x
|
0.69
|
Joby has a credible chance to turn a scarce certification-and-manufacturing lead into a regulated mobility network, but the real equity upside comes only if it converts milestones into dense, repeatable operations before capital intensity and fare elasticity cap value capture.
|
| 46 |
RCAT
|
aerospace
ai
defense
hardware
robotics
|
Red Cat Holdings, Inc.
|
2.5x
|
0.58
|
Red Cat can outgrow normal defense suppliers if Black Widow becomes a repeatable program, allied demand broadens the customer base, and the company shifts part of value capture from one-time hardware sales toward readiness, support, and trusted-control revenue; the limiting factor is that today’s stock price already assumes substantial success.
|
| 47 |
CRDO
|
ai
communications
hardware
networking
semiconductors
|
Credo Technology Group Holding Ltd
|
2.5x
|
0.68
|
Credo is a real AI infrastructure beneficiary because reliable, low-power data movement is becoming more valuable as clusters scale; the next five years depend on turning an AEC beachhead into a broader optical, DSP, IP, and assurance stack without losing economics to hyperscalers or larger bundled rivals.
|
| 48 |
LMND
|
ai
automation
finance
software
|
Lemonade, Inc.
|
2.5x
|
0.60
|
An AI-native carrier with real regulatory control points can still more than double equity value by 2031 if Car, multi-policy households, and embedded distribution convert data advantage into better loss ratios and lower acquisition cost; the win condition is becoming a clearly profitable premium insurer, not preserving a software aura.
|
| 49 |
APLD
|
ai
cloud
crypto
energy
hardware
|
Applied Digital Corporation
|
2.4x
|
0.64
|
Applied Digital can still compound equity meaningfully if it converts scarce, power-linked campuses into live long-duration AI rent faster than it adds capital burdens; the win condition is becoming a repeatable AI infrastructure manufacturer, not just a one-off project developer.
|
| 50 |
CORZ
|
ai
cloud
crypto
energy
|
Core Scientific, Inc.
|
2.4x
|
0.72
|
Core Scientific’s upside comes from turning a mining-era power footprint into contracted AI colocation faster than greenfield rivals; if it delivers the 590 MW ramp, adds more tenants, and funds growth with structured capital instead of only corporate debt, equity value can compound meaningfully even without a top-tier data-center multiple.
|
| 51 |
CRWV
|
ai
cloud
enterprise
hardware
software
|
CoreWeave, Inc.
|
2.4x
|
0.78
|
CoreWeave is a high-beta AI infrastructure compounder: if it keeps turning contracted power and backlog into live clusters faster than debt and dilution grow, it can scale from scarce-capacity seller into a broader AI runtime and tooling layer, supporting a materially larger business by 2031 even with a lower valuation multiple than today.
|
| 52 |
DDOG
|
ai
cloud
cybersecurity
enterprise
software
|
Datadog, Inc.
|
2.4x
|
0.63
|
Datadog is positioned to outgrow most enterprise software peers because AI makes software systems denser, noisier, and more security-sensitive; if it keeps turning telemetry presence into security, workflow, and governed-action spend, revenue can reach roughly 10 billion by 2031 without needing a return to peak-era valuation excess.
|
| 53 |
OKLO
|
ai
energy
healthcare
nuclear
|
Oklo Inc.
|
2.4x
|
0.72
|
Oklo is a scarce AI-power option on permissioned nuclear capacity: if it turns Idaho into operating proof, converts Ohio into funded execution, and monetizes fuel and isotope adjacencies, it can grow into a premium clean-power platform by 2031; if those gates slip, the current scarcity premium can compress hard.
|
| 54 |
WULF
|
ai
cloud
crypto
energy
|
TeraWulf Inc.
|
2.3x
|
0.60
|
TeraWulf is a levered bet on scarce powered AI campuses: if it converts signed megawatts and new brownfield sites into delivered, financeable, repeatable capacity, revenue can inflect from mining-era levels toward infrastructure-grade cash flows; the real governor is dilution and schedule discipline, not demand.
|
| 55 |
FIVN
|
ai
cloud
communications
enterprise
software
|
Five9, Inc.
|
2.3x
|
0.40
|
Five9 is a cash-generative cloud CX workflow layer trading at a trough valuation; if it proves AI automation can shift monetization from seats toward higher-value orchestration, partner distribution, and regulated trust, it can grow revenue at roughly low-double digits and rerate meaningfully without needing heroic share gains.
|
| 56 |
RGTI
|
cloud
enterprise
hardware
quantum
|
Rigetti Computing, Inc.
|
2.3x
|
0.45
|
Rigetti can still become a real sovereign-and-research quantum infrastructure niche by 2031 if 108-qubit fidelity improves, 150+ qubit scaling lands, and early hardware orders become recurring performance-backed revenue; the upside is non-linear from a tiny base, but today’s valuation means execution must now carry most of the return.
|
| 57 |
APP
|
advertising
ai
media
software
|
AppLovin Corporation
|
2.3x
|
0.66
|
AppLovin can extend an elite mobile-gaming ad engine into a broader AI performance-commerce network because its economics are tied to spend and outcomes rather than seats, Axon improves with more auction telemetry, and MAX is embedded in publisher workflows; if self-serve e-commerce scales without hurting auction quality, revenue can reach 22000 by 2031 despite policy risk and multiple compression.
|
| 58 |
BBAI
|
ai
cybersecurity
defense
enterprise
software
|
BigBear.ai Holdings, Inc.
|
2.3x
|
0.42
|
BigBear.ai can become a meaningfully larger secure mission-software company if Ask Sage, CargoSeer, and legacy defense workflows turn into audited, repeatable products rather than lumpy project work; that supports a 2-5x value path even with multiple compression, but only if backlog refills and software mix improves before dilution does more damage.
|
| 59 |
RIOT
|
ai
cloud
crypto
energy
hardware
|
Riot Platforms, Inc.
|
2.3x
|
0.61
|
Riot’s 5-year upside comes from converting scarce, already-approved Texas power from volatile bitcoin spread exposure into repeatable, financed, long-duration data-center revenue. The realistic win is a solid re-rating into a hybrid digital-infrastructure company, not a moonshot, because one live AMD deployment can unlock cheaper capital and more leases but funding and tenant concentration still cap the outcome.
|
| 60 |
KTOS
|
aerospace
automation
defense
software
space
|
Kratos Defense & Security Solutions, Inc.
|
2.3x
|
0.60
|
Kratos has a credible path to more than double equity value by 2031 if affordable autonomous aircraft, propulsion, hypersonic hardware, and space-ground control systems move from development-heavy wins into repeat production, with modest upside from recurring trust and mission-software layers rather than pure hardware alone.
|
| 61 |
SNOW
|
ai
cloud
enterprise
software
|
Snowflake Inc.
|
2.3x
|
0.60
|
Snowflake can outgrow software-market norms if it becomes the trusted governed runtime for enterprise AI and agent actions, not just a warehouse; that supports durable 2x-3x equity compounding by 2031, but open formats and hyperscaler competition likely cap the upside below true hypergrowth.
|
| 62 |
ASTS
|
aerospace
communications
defense
networking
space
|
AST SpaceMobile, Inc.
|
2.2x
|
0.60
|
AST can still become the carrier-embedded default layer for off-grid mobile coverage and resilience, turning scarce orbit, spectrum access, and gateway integration into a global communications utility; but from today, most equity upside requires repeatable launches, approvals, and monetization rather than another narrative-led rerating.
|
| 63 |
AVAV
|
aerospace
defense
robotics
software
space
|
AeroVironment, Inc.
|
2.2x
|
0.65
|
AeroVironment can still compound meaningfully by turning today’s real demand for autonomous strike, reconnaissance, counter-drone, and space systems into repeat production, broader allied distribution, and higher software and sustainment attach; the upside is operational scale and better mix, not a heroic pure-software rerating.
|
| 64 |
CRNC
|
ai
automotive
enterprise
software
|
Cerence Inc.
|
2.2x
|
0.50
|
Cerence can turn its embedded OEM distribution into a higher-value in-car AI control layer if 2026-2027 xUI launches prove production readiness and monetization shifts from volatile royalties toward recurring connected, trust, and action revenue.
|
| 65 |
TWST
|
ai
automation
biotech
healthcare
|
Twist Bioscience Corporation
|
2.2x
|
0.53
|
Twist can become a larger biology infrastructure business as AI makes sequence design cheaper and increases demand for trusted physical execution; if rising synthesis, sequencing, and antibody volumes translate into durable gross-margin gains, deeper workflow embedment, and a self-funding model, a little over 2x equity value by 2031 is plausible without requiring multiple expansion.
|
| 66 |
AMPX
|
aerospace
defense
energy
hardware
transportation
|
Amprius Technologies, Inc.
|
2.1x
|
0.58
|
Amprius can still grow revenue non-linearly as drones, defense systems and advanced mobility reward lighter batteries, but the equity is no longer early: upside now depends on turning qualifications into repeat shipments, protecting gross margin through partner-led scale, and adding trust and compliance layers that make the cells harder to replace.
|
| 67 |
CLS
|
ai
cloud
communications
hardware
networking
|
Celestica Inc.
|
2.1x
|
0.60
|
Celestica is one of the more credible AI infrastructure ‘picks-and-shovels’ stories outside semis: if it converts today’s hyperscaler ramps into a broader HPS-led manufacturing and lifecycle franchise, on-time capacity plus deeper customer embedding can still support roughly a doubling of enterprise value by 2031.
|
| 68 |
HUT
|
ai
cloud
crypto
energy
|
Hut 8 Corp.
|
2.1x
|
0.62
|
Hut 8 can create meaningful value by turning scarce powered sites into long-duration AI infrastructure cash flows, but from today's valuation shareholders likely need River Bend plus at least one repeat project funded mainly with project capital, not repeated equity issuance, for returns to be strong.
|
| 69 |
LSCC
|
ai
automation
cybersecurity
hardware
semiconductors
|
Lattice Semiconductor Corporation
|
2.1x
|
0.60
|
Lattice is a high-quality low-power programmable silicon franchise whose best five-year upside comes from owning more secure-control, AI-server, CXL sideband, and edge-system sockets; the business can compound hard, but shareholder upside is capped unless those wins convert into durable volume and a small recurring trust-software layer.
|
| 70 |
MRVL
|
ai
cloud
hardware
networking
semiconductors
|
Marvell Technology, Inc.
|
2.1x
|
0.74
|
Marvell can roughly double equity value by 2031 if it converts today’s AI design-win exposure into a broader shipped-volume franchise across custom silicon, optics and switching, but the payoff depends on keeping scarce supply aligned and staying embedded with a small number of hyperscaler customers.
|
| 71 |
PANW
|
ai
cloud
cybersecurity
enterprise
software
|
Palo Alto Networks, Inc.
|
2.1x
|
0.74
|
PANW can still compound into a little over 2x enterprise value by 2031 because AI expands the number of identities, agents, clouds, browsers, and actions that must be governed, while PANW already controls several enterprise security checkpoints and can deepen wallet share through platformization, identity, observability, browser, and AI-runtime controls.
|
| 72 |
RKLB
|
aerospace
defense
hardware
space
|
Rocket Lab Corporation
|
2.1x
|
0.68
|
Rocket Lab is evolving from a niche launcher into a vertically integrated space-and-defense capacity owner; if Neutron is validated and the company keeps attaching components, payloads, and operations to each mission, revenue can scale non-linearly, but today’s equity value already prices in a large share of that future.
|
| 73 |
AMD
|
ai
hardware
networking
semiconductors
software
|
Advanced Micro Devices, Inc.
|
2.1x
|
0.72
|
AMD is one of the few credible non-Nvidia compute suppliers that can compound value through 2031 by pairing server CPU share gains with a durable No. 2 AI accelerator and rack-scale position, but the stock already prices in meaningful success so upside depends on delivered volume, not roadmap headlines.
|
| 74 |
META
|
advertising
ai
communications
hardware
media
|
Meta Platforms, Inc.
|
2.1x
|
0.72
|
Meta is a rare mega-cap where AI already improves the core cash engine: better ranking, creative, and measurement lift advertiser ROI on owned surfaces today, while messaging commerce, trust infrastructure, and wearables can add second-leg monetization over five years if compute buildout stays disciplined.
|
| 75 |
RMBS
|
ai
cybersecurity
hardware
semiconductors
|
Rambus Inc.
|
2.1x
|
0.65
|
Rambus is an asset-light way to own rising AI memory complexity: if it converts DDR5, MRDIMM, high-bandwidth-memory controller IP and security attach into sustained chip, royalty and workflow revenue, revenue can more than double by 2031, though the stock outcome is capped by an already-premium starting valuation.
|
| 76 |
SYM
|
ai
automation
enterprise
robotics
software
|
Symbotic Inc.
|
2.1x
|
0.68
|
Symbotic can turn a very large contracted backlog into a much bigger installed base and service annuity as AI makes warehouse coordination and labor substitution more valuable, but the stock’s upside is constrained by Walmart concentration, deployment throughput, and a starting valuation that already prices in a lot of success.
|
| 77 |
NTRA
|
ai
biotech
healthcare
medical devices
|
Natera, Inc.
|
2.0x
|
0.62
|
Natera can compound from a fast-growing test vendor into an oncology-centered precision-diagnostics control point if Signatera keeps converting clinical evidence into covered reimbursement, treatment-pathway use, and deeper workflow embedment; AI should improve assay design and operating efficiency, but the upside still depends more on payer and regulatory conversion than on pure software leverage.
|
| 78 |
ORCL
|
ai
cloud
enterprise
healthcare
software
|
Oracle Corporation
|
2.0x
|
0.72
|
Oracle can still create strong shareholder value from mega-cap scale if it converts contracted AI and multicloud demand into live OCI usage while defending its systems-of-record moat; the upside comes more from delivered revenue and later cash-flow normalization than from a heroic valuation re-rating.
|
| 79 |
ARM
|
ai
enterprise
hardware
semiconductors
software
|
Arm Holdings plc
|
2.0x
|
0.80
|
Arm is an AI-era architecture tollbooth: if it keeps lifting royalty dollars per chip through Armv9, CSS, Neoverse and selective silicon, revenue can compound rapidly across cloud, mobile, automotive and edge, but shareholder returns will still be moderated by an already premium starting valuation.
|
| 80 |
MSFT
|
ai
cloud
cybersecurity
enterprise
software
|
Microsoft Corporation
|
2.0x
|
0.84
|
Microsoft can remain a top AI-era compounder because it monetizes machine labor at three layers at once: Azure compute, enterprise identity/governance, and the daily workflow surface in Microsoft 365, GitHub, and Dynamics. That mix makes it more than a model reseller and lets it convert AI adoption into both usage revenue and stronger enterprise lock-in.
|
| 81 |
PL
|
aerospace
defense
enterprise
software
space
|
Planet Labs PBC
|
2.0x
|
0.70
|
Planet owns a scarce daily Earth-data archive and an increasingly sovereign-facing satellite-services stack; if it converts backlog into verified, machine-native geospatial workflows, revenue can compound far faster than traditional aerospace peers, but equity upside is capped by today’s already rich valuation and the need to execute a physical fleet build.
|
| 82 |
COHR
|
ai
communications
hardware
networking
semiconductors
|
Coherent Corp.
|
1.9x
|
0.72
|
Coherent is a scarce AI-physical bottleneck: if it converts qualified photonics capacity, design-win stickiness, and higher-speed optical content into cleaner margins and lower leverage before supply loosens, it can still roughly double equity value by 2031 despite an already rich starting valuation.
|
| 83 |
PLTR
|
ai
automation
defense
enterprise
software
|
Palantir Technologies Inc.
|
1.9x
|
0.74
|
Palantir is one of the few application-layer AI companies with real control points in sensitive workflows; if it keeps converting AIP demand into durable production subscriptions and monetizes trust, governance, and outcome layers, revenue can compound hard, but most shareholder upside from here must come from execution rather than fresh valuation expansion.
|
| 84 |
AMZN
|
advertising
ai
cloud
enterprise
transportation
|
Amazon.com, Inc.
|
1.9x
|
0.80
|
Amazon can still roughly double equity value by 2031 if it turns today’s AI capacity shortage into durable AWS throughput, trusted agent controls, and higher-margin mix from ads, seller services, and subscriptions while automation keeps retail margins compounding.
|
| 85 |
AVGO
|
ai
enterprise
networking
semiconductors
software
|
Broadcom Inc.
|
1.9x
|
0.80
|
Broadcom is one of the few mega-caps that still has credible non-linear upside because it sits at two durable AI control points: custom accelerator and Ethernet buildouts for very large cloud customers, and sticky private-cloud software inside enterprises. The five-year win is more about revenue duration and mix quality than heroic multiple expansion.
|
| 86 |
NVDA
|
ai
hardware
networking
semiconductors
software
|
NVIDIA Corporation
|
1.9x
|
0.95
|
NVIDIA can still create strong shareholder value from a huge base because it remains the default AI factory stack across compute, network fabric, systems and deployment software; the nonlinear upside is capturing more of each deployment through rack-scale systems, sovereign infrastructure and higher software attach, not just shipping more chips.
|
| 87 |
SNPS
|
ai
cloud
enterprise
semiconductors
software
|
Synopsys, Inc.
|
1.9x
|
0.78
|
Synopsys looks like an AI-era engineering toll road: rising chip and system complexity should deepen demand for its trusted workflow, verification, IP, and simulation stack, while the Ansys deal expands wallet share from silicon into system physics; if integration and Design IP execution land, the stock can still compound well from a reset base.
|
| 88 |
FN
|
ai
automation
communications
hardware
networking
|
Fabrinet
|
1.9x
|
0.63
|
Fabrinet is one of the few scaled, profitable ways to own the AI-optics buildout through scarce qualified manufacturing capacity; if it fills new Thailand space with harder photonics programs and captures slightly better economics around supply assurance and lifecycle services, revenue can roughly double by 2031 even if the valuation multiple cools.
|
| 89 |
JBL
|
automation
cloud
hardware
healthcare
networking
|
Jabil Inc.
|
1.9x
|
0.58
|
Jabil can keep compounding as AI pushes more dollars into hard-to-ramp hardware, power, cooling, and regulated builds, lifting mix, cash flow, and buyback capacity; the ceiling is less about demand than whether it can defend improved economics before customers rebid or insource more of the value chain.
|
| 90 |
MU
|
ai
hardware
semiconductors
|
Micron Technology, Inc.
|
1.9x
|
0.80
|
Micron is one of the few mega-cap AI names whose control point is still physical scarcity: qualified memory, packaging and capacity. Over the next five years it can grow materially if it converts today's HBM and server-memory shortage into deeper platform design-ins, higher content per AI rack and more contract-like revenue, but its product-margin model still caps upside versus software-like AI winners.
|
| 91 |
SITM
|
ai
communications
hardware
networking
semiconductors
|
SiTime Corporation
|
1.9x
|
0.50
|
SiTime can roughly quadruple revenue by 2031 if it closes the Renesas timing deal, expands from oscillator sockets into broader clocking content, and keeps winning high-value AI/datacenter, communications and automotive designs; the business is well aligned with AI infrastructure, but most shareholder upside now depends on execution and scale rather than another major rerating.
|
| 92 |
VICR
|
ai
defense
hardware
networking
semiconductors
|
Vicor Corporation
|
1.9x
|
0.65
|
Vicor is a real AI-era power-density enabler with credible technical differentiation, but the five-year investment case depends less on proving demand than on converting backlog into qualified volume, broadening beyond lead accounts, and earning more of the stack before its premium valuation compresses.
|
| 93 |
CDNS
|
ai
enterprise
hardware
semiconductors
software
|
Cadence Design Systems, Inc.
|
1.9x
|
0.74
|
Cadence should keep compounding as AI, chiplets, and physics-heavy system design push more spend into trusted engineering workflows it already controls across design, verification, IP, emulation, and simulation, but the stock is more likely to reward investors through steady execution than a fresh valuation surge.
|
| 94 |
CRM
|
ai
automation
cloud
enterprise
software
|
Salesforce, Inc.
|
1.9x
|
0.60
|
Salesforce is best viewed as a mature but still under-monetized enterprise workflow control point: if it can turn Agentforce, Data Cloud, Slack, and Informatica into additive governed automation spend rather than a repackaging of seat licenses, the business can compound into a much larger cash generator and roughly double equity value by 2031 without needing peak-SaaS valuation exuberance.
|
| 95 |
DELL
|
ai
cloud
enterprise
hardware
networking
|
Dell Technologies Inc.
|
1.9x
|
0.62
|
Dell is a strong AI-infrastructure beneficiary, but the real upside is not just shipping more AI servers; it is turning those deployments into a broader, stickier enterprise stack with storage, services, financing and trust layers that keep Dell relevant as AI moves from pilots to production.
|
| 96 |
MPWR
|
ai
automotive
communications
hardware
semiconductors
|
Monolithic Power Systems, Inc.
|
1.9x
|
0.65
|
MPS is a high-quality power-density enabler whose revenue can compound strongly through AI rack power, module mix, and automotive electrification, but with the stock already priced at a premium, shareholder upside depends more on proving durable socket control and margin resilience than on simple multiple expansion.
|
| 97 |
TSLA
|
ai
automotive
energy
robotics
transportation
|
Tesla, Inc.
|
1.9x
|
0.62
|
Tesla can still roughly double enterprise value by 2031 if energy storage, charging/account monetization and partial commercial autonomy become a larger share of revenue, allowing growth beyond car units without needing a full robotaxi or humanoid-robot blowout.
|
| 98 |
TSM
|
ai
hardware
semiconductors
|
Taiwan Semiconductor Manufacturing Company Limited
|
1.9x
|
0.90
|
TSMC is the highest-quality manufacturing bottleneck in AI: if it keeps converting N3/N2 and advanced-packaging scarcity into shipped output while holding pricing discipline and yield leadership, revenue can more than double by 2031, but shareholder returns should be solid rather than explosive because the stock already prices in much of that strategic value.
|
| 99 |
BKSY
|
aerospace
ai
defense
software
space
|
BlackSky Technology Inc.
|
1.8x
|
0.64
|
BlackSky is one of the few small caps that pairs scarce orbital collection with workflow software, so Gen-3 and sovereign offerings can still drive strong revenue growth; the issue is not whether demand exists, but whether recurring mix, launch cadence, and financing improve fast enough to outrun a valuation that already assumes meaningful success.
|
| 100 |
AAOI
|
ai
communications
hardware
networking
semiconductors
|
Applied Optoelectronics, Inc.
|
1.8x
|
0.62
|
AOI is a real AI-bandwidth bottleneck beneficiary because it owns laser-to-transceiver manufacturing that customers need now, but from today’s valuation the next five years are mainly about converting scarce capacity into durable, profitable scale before optics pricing normalizes.
|
| 101 |
ANET
|
ai
cloud
hardware
networking
software
|
Arista Networks, Inc.
|
1.8x
|
0.70
|
Arista is a high-quality AI-era networking toll collector: it already ships at scale, owns a sticky operating layer in EOS and CloudVision, and can compound revenue through AI fabrics, campus, WAN, and higher-value assurance software, but the stock starts from a demanding valuation so shareholder upside should come more from execution than rerating.
|
| 102 |
GOOG
|
advertising
ai
cloud
enterprise
media
|
Alphabet Inc.
|
1.8x
|
0.80
|
Alphabet is one of the few mega-caps positioned to capture more value as cognition gets cheaper: it owns mass user intent, self-funded compute, and growing enterprise trust layers, so resilient Search/YouTube economics plus Cloud, security, and agent workflows can drive a much larger 2031 revenue base even if regulation limits multiple expansion.
|
| 103 |
NET
|
cloud
cybersecurity
enterprise
networking
software
|
Cloudflare, Inc.
|
1.8x
|
0.67
|
Cloudflare is one of the clearer Last Economy beneficiaries because it sits directly in the path of internet traffic, security policy, and emerging machine-to-machine activity; if it keeps converting that control point into deeper enterprise standardization and paid usage, revenue can compound sharply even while the stock’s premium multiple compresses.
|
| 104 |
CRWD
|
ai
cloud
cybersecurity
enterprise
software
|
CrowdStrike Holdings, Inc.
|
1.8x
|
0.72
|
CrowdStrike remains an AI-era cyber compounder: AI expands the attack surface, telemetry volume and machine-identity sprawl, while Falcon’s shared data, one-agent deployment and Flex-led procurement help capture more wallet share. The five-year upside is real, but from a $113,000 million starting value the likely outcome is strong compounding rather than an effortless multibagger.
|
| 105 |
ETN
|
aerospace
automation
energy
hardware
software
|
Eaton Corporation plc
|
1.8x
|
0.70
|
Eaton is positioned to collect more value as AI makes compute abundant and reliable power delivery scarcer: its advantage is not software seats but specified hardware, channel trust, manufacturing slots, and an expanding power-plus-cooling stack that can raise content per megawatt while the Mobility separation improves mix.
|
| 106 |
NTAP
|
ai
cloud
enterprise
hardware
software
|
NetApp, Inc.
|
1.8x
|
0.55
|
NetApp is not an AI model winner, but it can still compound value if it keeps turning its installed storage base and hyperscaler embeds into a trusted control layer for hybrid cloud, cyber recovery, and AI-era data operations; that supports high-single-digit revenue growth and a modest quality rerating by 2031.
|
| 107 |
PWR
|
automation
cloud
communications
energy
|
Quanta Services, Inc.
|
1.8x
|
0.60
|
Quanta is a scarce execution layer for the AI-era power buildout: rising grid, generation and large-load demand should expand its revenue and mix faster than ordinary contractors, but the real test is whether it can convert labor, training and customer embed into earlier-lifecycle, better-priced and more recurring value capture rather than staying mostly a premium project contractor.
|
| 108 |
TLN
|
ai
energy
nuclear
|
Talen Energy Corporation
|
1.8x
|
0.70
|
Talen can roughly double equity value by 2031 if it keeps turning scarce PJM-area nuclear and gas megawatts into longer-duration AI-load and capacity cash flows, closes and integrates Cornerstone, and uses the cash step-up to reduce leverage faster than the market expects.
|
| 109 |
ON
|
ai
automation
automotive
hardware
semiconductors
|
ON Semiconductor Corporation
|
1.7x
|
0.60
|
onsemi can grow into a higher-quality power-and-sensing franchise if it converts cyclical recovery into sustained share gains in automotive, industrial, and AI power, but the stock now needs real utilization and mix proof rather than just a rebound narrative.
|
| 110 |
VST
|
energy
nuclear
|
Vistra Corp.
|
1.7x
|
0.72
|
Vistra is a strong Last Economy beneficiary because AI makes reliable grid-ready power scarcer; over five years it can turn nuclear and gas scarcity into more contracted cash flow, add Cogentrix scale, and compound equity at a mid-teens rate if leverage and licensing stay on plan.
|
| 111 |
MTSI
|
communications
defense
hardware
networking
semiconductors
|
MACOM Technology Solutions Holdings, Inc.
|
1.7x
|
0.70
|
MACOM is a real AI-connectivity enabler with scarce RF/photonics process know-how, trusted U.S. manufacturing and improving fab leverage, but the stock already discounts a lot; the 5-year case depends on turning 1.6T/3.2T, copper-link and defense design activity into sustained high-volume shipments faster than valuation compresses.
|
| 112 |
STEM
|
ai
automation
energy
enterprise
software
|
Stem, Inc.
|
1.7x
|
0.50
|
Stem has a credible chance to turn a real but financially constrained clean-energy control stack into a higher-quality recurring software and services business; if it proves retention, mix, and financing durability, enterprise value can rise meaningfully, but debt and dilution will likely absorb part of what operations create.
|
| 113 |
VRT
|
ai
automation
cloud
communications
hardware
|
Vertiv Holdings Co.
|
1.7x
|
0.80
|
Vertiv is a real AI-infrastructure beneficiary because rising rack density increases the power, cooling, prefab and service content per deployment, and Vertiv owns credible control points in those layers; the catch is that much of the scarcity premium is already in the stock, so 5-year returns likely come from sustained execution and mix improvement more than another large rerating.
|
| 114 |
CEG
|
energy
enterprise
nuclear
|
Constellation Energy Corporation
|
1.7x
|
0.80
|
Constellation should be a durable AI-era power scarcity winner because it controls licensed clean baseload, dispatchable backup, grid-ready sites, and enterprise contracting reach; the main question is not demand, but how much of that scarcity it can turn into premium long-duration earnings from an already premium starting valuation.
|
| 115 |
ASML
|
automation
hardware
semiconductors
software
|
ASML Holding N.V.
|
1.6x
|
0.88
|
ASML should remain one of the cleanest AI-capex toll booths through 2031: advanced logic and DRAM need more EUV layers, more productivity upgrades and eventually more next-generation EUV systems, lifting revenue materially. But because the stock already trades as a recognized scarcity asset, most shareholder upside should come from revenue and mix compounding rather than a dramatic rerating.
|
| 116 |
BWXT
|
aerospace
defense
energy
healthcare
nuclear
|
BWX Technologies, Inc.
|
1.6x
|
0.76
|
BWXT should keep compounding as a scarce, licensed nuclear manufacturing and defense-fuel bottleneck: backlog conversion, commercial capacity expansion and adjacent fuel opportunities can lift revenue meaningfully by 2031, but the stock already reflects much of that scarcity so execution and cash conversion matter more than narrative alone.
|
| 117 |
LITE
|
ai
communications
hardware
networking
semiconductors
|
Lumentum Holdings Inc.
|
1.6x
|
0.70
|
Lumentum is a real AI-infrastructure bottleneck owner: if it converts scarce photonics capacity, OCS adoption, and next-wave laser content into durable systems share, revenue can more than double by 2031, but most equity upside is capped by an already rerated starting valuation.
|
| 118 |
EQIX
|
ai
cloud
enterprise
networking
software
|
Equinix, Inc.
|
1.6x
|
0.80
|
Equinix should keep compounding as AI raises the value of scarce metro power, neutral interconnection and trusted private infrastructure; the upside is real, but for shareholders it likely comes from more sellable capacity, better network/software attach and selective scarcity monetization rather than a venture-style rerating.
|
| 119 |
HPE
|
cloud
enterprise
hardware
networking
software
|
Hewlett Packard Enterprise Company
|
1.5x
|
0.58
|
HPE can become a better-quality infrastructure compounder over the next five years if Juniper lifts networking mix, GreenLake deepens operational stickiness, and AI demand converts into profitable shipments; the upside is real but comes from better value capture and cash generation, not from turning into a pure software platform.
|
| 120 |
NEE
|
ai
energy
nuclear
|
NextEra Energy, Inc.
|
1.5x
|
0.74
|
NextEra is one of the clearest power-side beneficiaries of AI and electrification because it pairs a captive Florida utility with a scaled development engine, but the payoff is more likely premium compounding than explosive upside because regulation and financing absorb part of the scarcity rent.
|